GLP-1 Medications and Their Impact on Sex Lives

As the popularity of GLP-1 medications continues to soar, conversations around these medications have largely centered on their effectiveness in treating type 2 diabetes and aiding weight loss efforts. However, some scientists are now starting to investigate the potential impact of GLP-1s on our sex lives.

At present, roughly one in five Americans reports taking or having taken a GLP-1 medication, according to a recent poll. As the number of people using these medications has increased, so have anecdotal reports about how they’re impacting users’ day-to-day lives, including their sex drive.

How GLP-1s Work

GLP-1 medications, such as Ozempic and Wegovy, contain a synthetic version of a naturally occurring hormone called glucagon-like peptide-1 (GLP-1). This hormone helps regulate appetite, blood sugar, and feelings of satiety. When taken, GLP-1 medications mimic the action of GLP-1 in the body, helping to reduce hunger and increase feelings of fullness.

Other options, like Zepbound and Mounjaro, contain a different active ingredient called tirzepatide, which mimics both GLP-1 and a related hormone. This impacts the body in similar ways to semaglutide, the active ingredient in Ozempic and Wegovy.

The Relationship Between GLP-1s and Sex Drive

While research into the relationship between GLP-1s and sex drive is still limited, some scientists are starting to investigate the potential impact of these medications on our sex lives. In a review published in Obesity Pillars in March 2026, researchers propose that GLP-1s may influence desire by impacting brain chemistry.

One theory is that GLP-1s may affect certain serotonin receptors, including one called 5-HT2C. This is thought to be a key player in the sexual side effects often experienced by those taking selective serotonin reuptake inhibitors (SSRIs), such as reduced libido and delayed orgasm.

The Impact of GLP-1s on Pelvic Floor Function

Sexual function isn’t just about hormones and brain chemistry; it also depends on the pelvic floor, a group of muscles that support the bladder and bowel, among other organs. These muscles play an active role in arousal and orgasm.

In general, weight loss from GLP-1s or other methods can improve pelvic-floor function because reduced abdominal pressure means the muscles don’t have to work as hard to support the pelvic organs. However, GLP-1s can also lead to relatively rapid weight loss, which can be challenging to preserve lean muscle mass without adequate protein intake or resistance training.

This can lead to a condition called sarcopenia, which some studies have linked to reduced pelvic floor function. Additionally, muscle loss can occur no matter how you lose weight, but GLP-1s may speed up muscle loss as well.

The Connection Between GLP-1s and Embodiment

Weight loss does not automatically translate to increased body confidence and desire. Particularly if you have a long history of having your body policed against external beauty standards, rapid physical changes can lead to feelings of unfamiliarity in your body.

Sexual desire and pleasure are often closely tied to embodiment, so a lack of embodiment can impact intimacy. However, some people may experience improved aspects of sexual well-being due to the broader health changes associated with GLP-1s.